Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-12-05
1992-03-17
Willis, Jr., Prince
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514929, A61K 3152
Patent
active
050969064
ABSTRACT:
A family of compounds effective in inhibiting interleukin-1 (IL-1) activity, tumor necrosis factor (TNF) activity, and the activity of other leukocyte derived cytokines is comprised of 7-(oxoalkyl) 1,3-dialkyl xanthines of the formula ##STR1## in which R.sub.1 and R.sub.2 are the same or different and are selected from the group consisting of straight-chain or branched alkyl radicals with 2 to 6 carbon atoms, cyclohexyl, alkoxyalkyl and hydroxyalkyl radicals, and A represents a hydrocarbon radical with up to 4 carbon atoms which can be substituted by a methyl group. Another family of effective compounds is identified as ##STR2## The inhibition of IL-1, TNF, and other cytokines in mammals is implicated in alleviation of a wide variety of disease conditions.
REFERENCES:
patent: 4002756 (1977-01-01), Higuchi et al.
patent: 4225607 (1980-09-01), Goring et al.
patent: 4242345 (1980-12-01), Brenner et al.
patent: 4289776 (1981-09-01), Mohler et al.
patent: 4291037 (1981-09-01), Brenner et al.
patent: 4372959 (1983-02-01), Goring
patent: 4454138 (1984-06-01), Goring
patent: 4511557 (1985-04-01), Gauri
patent: 4515795 (1985-05-01), Hinze et al.
patent: 4576947 (1986-03-01), Hinze et al.
patent: 4636507 (1987-01-01), Kreutzer et al.
patent: 4657910 (1987-04-01), Morgan
patent: 4719212 (1988-01-01), Goto et al.
patent: 4784999 (1988-11-01), Angersbach et al.
patent: 4965271 (1990-10-01), Mandell et al.
Mossec, P. et al, Chem. Abstracts, 101:168805u (1984).
Kuratsuji, T. et al, Chem. Abstracts, 104:218828p (1986).
Sullivan et al, Transact. Assn. Am. Phys., 97:337-345 (1984).
Furuzawa, S. et al, Chem. Abstracts, 95:20770r (1981).
Nakayama T. et al, Bio. Abstracts, 78:77203 (1984).
Mandell Gerald L.
Novick William J.
Sullivan Gail W.
Hoechst Roussel Pharmaceuticals Inc.
McAvoy Ellen
University of Virginia Alumni Patents Foundation
Willis Jr. Prince
LandOfFree
Method of inhibiting the activity of leukocyte derived cytokines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting the activity of leukocyte derived cytokines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting the activity of leukocyte derived cytokines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1476059